T lymphocytes (T cells) not only play very important roles in adaptive immunity against various pathogens and malignancies but also contribute substantially to the pathogenesis of many autoimmune and allergic diseases. GATA-3 has emerged as a key transcription factor that controls the development and function of T cells. GATA-3 is not only essential for the development of the T cell lineage but also important for the production of T cell cytokines, including IL-4, IL-5, IL-13, and IL-10. In addition, studies on genetically engineered mice over-expressing GATA-3 have implied that GATA-3 may have a broader effect on T cell biology. Therefore, a better understanding of the function and regulation of GATA-3 will significantly advance our knowledge about the initiation, maintenance, and cessation of immune responses, and greatly enhance our ability to manipulate the outcomes of many infectious, malignant, inflammatory, and autoimmune diseases. However, the molecular mechanisms regulating the expression of GATA-3 are poorly understood, and studies on the function of GATA-3 are markedly hampered by the lack of live animals carrying mature GATA-3-deficient T cells. This grant application is designed to take advantage of the recently generated conditional GATA-3-deficient mice to study the regulatory role and mechanism of action of GATA-3 in later stages of T cell development (Aim 1) and in the function of various subsets of peripheral T cells (Aims 2 and 3). One attractive explanation for the broad range of function of GATA-3 in T cells is that GATA-3 is able to interact physically and functionally with various proteins. This possibility will be addressed with several in vitro approaches (Aim 4). In addition, a great effort will be dedicated to elucidating the molecular mechanisms mediating the cell type-specific expression of GATA-3 (Aim 5).

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI054451-03
Application #
6983434
Study Section
Allergy and Immunology Study Section (ALY)
Program Officer
Mallia, Conrad M
Project Start
2003-12-01
Project End
2008-11-30
Budget Start
2005-12-01
Budget End
2006-11-30
Support Year
3
Fiscal Year
2006
Total Cost
$323,612
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Tai, Tzong-Shyuan; Pai, Sung-Yun; Ho, I-Cheng (2013) GATA-3 regulates the homeostasis and activation of CD8+ T cells. J Immunol 190:428-37
Ho, I-Cheng; Tai, Tzong-Shyuan; Pai, Sung-Yun (2009) GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation. Nat Rev Immunol 9:125-35
Pai, Sung-Yun; Kang, Bok Yun; Sabadini, Amelia M et al. (2008) Distinct structural requirements of GATA-3 for the regulation of thymocyte and Th2 cell differentiation. J Immunol 180:1050-9
Kim, Peter J; Pai, Sung-Yun; Brigl, Manfred et al. (2006) GATA-3 regulates the development and function of invariant NKT cells. J Immunol 177:6650-9
Grenningloh, Roland; Kang, Bok Yun; Ho, I-Cheng (2005) Ets-1, a functional cofactor of T-bet, is essential for Th1 inflammatory responses. J Exp Med 201:615-26